Increased interleukin-2 level in patients with primary hypothyroidism
- 31 May 1992
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 63 (2) , 200-202
- https://doi.org/10.1016/0090-1229(92)90014-f
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Immunopathological features of human pulmonary tumors following low-dose interleukin-2Cancer Immunology, Immunotherapy, 1991
- Interleukin-2 toxicity.Journal of Clinical Oncology, 1991
- Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinomaEuropean Journal of Cancer and Clinical Oncology, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- HYPOTHYROIDISM AND GOITRE DURING INTERLEUKIN-2 THERAPY WITHOUT LAK CELLSThe Lancet, 1989
- A molecular basis for bidirectional communication between the immune and neuroendocrine systems.Physiological Reviews, 1989
- Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer CellsNew England Journal of Medicine, 1988
- High-Dose Recombinant Interleukin 2 in the Treatment of Patients With Disseminated CancerJAMA, 1986
- Interleukin l and T Cell ActivationImmunological Reviews, 1982
- The functional relationship of the interleukins.The Journal of Experimental Medicine, 1980